Conclusion: To our knowledge, this is the largest contemporary review of pharmacological agents for the treatment of generalised anxiety disorder by use of network analysis. There are several effective treatment choices for generalised anxiety disorder across classes of medication. The failure of initial pharmacological therapy might not be a reason to abandon a pharmacological treatment strategy.
PubMed 30712879 ↗Buspirone
Also known as Buspar
The short answer. People are split on Buspirone — 53% of 34 say it helped. It is most often used for anxiety: 76% of 33 reports say that improved. It is well studied — 68 meta-analyses on PubMed. The most common complaint is dizziness.
From 66 mentions in total — the rest didn't say how it went and aren't counted.
What Buspirone does, according to users
Of the people who reported each effect, the share who said it got better.
5 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 68 meta-analyses on PubMed ↗ · 240 randomized trials ↗
Conclusion: Numerous interactions between herbal medicines and conventional drugs have been documented. While the significance of many interactions is uncertain, several interactions, particularly those with St John's wort, may have serious clinical consequences.
PubMed 19719333 ↗Conclusion: In this systematic review we present information relating to the effectiveness and safety of the following interventions: applied relaxation, benzodiazepines, breathing retraining, brief dynamic psychotherapy, buspirone, client-centred therapy, cognitive behavioural therapy (CBT) (alone or plus drug treatments), cognitive restructuring, couple therapy, exposure (external or interoceptive), insight-orientated therapy, monoamine oxidase inhibitors (MAOIs), psychoeducation, selective serotonin reuptake inhibitors (SSRIs), self-help, and tricyclic antidepressants (imipramine).
PubMed 19445787 ↗Conclusion: This study underscores the efficacy and tolerability of several pharmacotherapies in managing agitation among children and adults with ASD or ID. Our findings provide robust evidence that specific treatments, such as arbaclofen, risperidone plus buspirone and omega-3 fatty acids, are both effective and well-tolerated, offering valuable therapeutic options for clinicians. The study emphasizes the need for ongoing research to ensure that treatment strategies remain aligned with the evolving clinical landscape, ultimately improving patient outcomes in this challenging population.
PubMed 39690490 ↗72 human trials on ClinicalTrials.gov test Buspirone — 48 completed, 7 recruiting now. See all on ClinicalTrials.gov ↗
- Buspirone for the Treatment of Traumatic Brain Injury (TBI) Irritability and Aggression · Traumatic Brain Injury · 2025
- Improving Ventilatory Capacity in Those With Chronic High Level SCI · Spinal Cord Injuries · 2024
- Effects of Buspirone Combined With Clozapine · Schizophrenia · 2023
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
The current US prescription label has no boxed warning.
11 recalls of products named for Buspirone. Most recent:
- 2026-05-13 · Class III: Subpotent drug record ↗
- 2023-11-29 · Class III: Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots record ↗
- 2023-05-03 · Class II: CGMP Deviations record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
10,970 adverse-event reports mention Buspirone. Most often reported:
- Fatigue · 800
- Nausea · 797
- Headache · 731
- Drug ineffective · 671
- Anxiety · 668
- Dyspnoea · 584
Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗
LiverTox rates Buspirone E — an unlikely cause of liver injury. LiverTox entry ↗
NIH has funded 15 research projects with Buspirone in the title, $3,445,737 in total (1985–2014). NIH RePORTER ↗
Plain-language guides from the US government: MedlinePlus: Buspirone ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“I’ve been taking the buspar these last couple days and it seems to handle my level of anxiety quite well.”
“came back with Buspirone which is not an SSRI. It has its own issues, but I could sleep.”
“I've been on 5 mg twice a day for about a year. I can't really notice the effects on anxiety, but when I ran out...my anxiety was through the roof.”
“The only drugs that has helped at all so far have been Buspar and Remeron, both of which eventually stopped working for me.”
Top discussions (5)
- Brain Has Felt “Offline” Since Childhood. Does This Sound Familiar? ↗
- Some tips for dealing with anxiety ↗
- What's a good alternative to alcohol and weed for social settings? ↗
- Case Study: The Hidden Dangers of Supplement and Medication Stacking — And How I Finally Took Control of My Health ↗
- This subreddit is turning increasingly delusional. What the FUCK people? ↗
Buspirone compared
Other options for anxiety
Sources
- User reports: 66 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA drug label (DailyMed) ↗
- FDA adverse-event reports (FAERS) ↗
- FDA recalls ↗
- LiverTox (NIH) ↗
- MedlinePlus (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate